Covered recipient · General Payments record
PAULINE M COLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$9,188.18
- Reported across 136 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,483.02 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $196.79 | 2 |
| CVRx Inc. | $133.31 | 1 |
| JAZZ PHARMACEUTICALS INC. | $130.70 | 1 |
| Neurocrine BioSciences, Inc. | $124.99 | 1 |
| Gilead Sciences, Inc. | $124.46 | 1 |
| EISAI INC. | $124.46 | 1 |
| Deciphera Pharmaceuticals Inc. | $124.30 | 1 |
| GlaxoSmithKline, LLC. | $121.84 | 1 |
| PFIZER INC. | $105.62 | 1 |
| Daiichi Sankyo Inc. | $102.50 | 1 |
| Abbott Laboratories | $92.53 | 1 |
| COLOPLAST CORP | $67.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $92.53 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125033792 | CMS |
| ABBVIE INC. | $103.94 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106935253 | CMS |
| ABBVIE INC. | $92.85 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106935255 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.15 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117984622 | CMS |
| COLOPLAST CORP | $67.37 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117439127 | CMS |
| CVRx, Inc. | $133.31 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127782542 | CMS |
| Daiichi Sankyo Inc. | $102.50 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089410248 | CMS |
| Deciphera Pharmaceuticals Inc. | $124.30 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145876551 | CMS |
| Eisai Inc. | $124.46 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110817968 | CMS |
| Gilead Sciences, Inc. | $124.46 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133662288 | CMS |
| GlaxoSmithKline, LLC. | $121.84 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116386344 | CMS |
| JAZZ PHARMACEUTICALS INC. | $130.70 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151303296 | CMS |
| Neurocrine Biosciences, Inc. | $124.99 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150921078 | CMS |
| PFIZER INC. | $105.62 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131471355 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.